2024-11-17 10:02:32
I-Mab and Genexine Announce China IND Approval for Innovative Immunotherapy
Health/ 2023-07-22
I-Mab and Genexine Announce China IND Ap...

SHANGHAI,Nov. 2,2018-- I-MAB Biopharma Co.,Ltd. ("I-Mab"),a Shanghai-based biotech company exclusively focused on innovative biolo...

China Biologic Reports Financial Results for the Third Quarter of 2018
Corporate/ 2023-07-23
China Biologic Reports Financial Results...

3Q18 Total Sales Up 21.9% YoY in RMB terms,or 19.6% YoY in USD terms; Non-GAAP Adjusted Net Income Down 12.7% YoY in RMB terms;

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release